Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Genet Med. 2023 Jul 5;25(11):100925. doi: 10.1016/j.gim.2023.100925

Table 3.

Strength of PVOD/PCH-EIF2AK4 relationship.

Gene Gene name MOIa Genetic evidence Variant type scoredb Experimental evidence Evidence type scoredc Total score >3 yrs? Classification Tissue/cell expressiond Molecular mechanisme
EIF2AK4 Eukaryotic translation initiation factor 2 alpha kinase 4 AR 12 pLOF, missense 0.5 F/expression 12.5 Y 2014 Definitive Lung, PASMCs LOF

PVOD/PCH, pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.

a

AR, autosomal recessive

b

pLOF, predicted loss of function, including nonsense, frameshift, and canonical splice variants.

c

F, function (relevant expression).

d

PASMCs, pulmonary artery smooth muscle cells.

e

LOF, loss of function.